Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P140009/S132

Liberta RC Deep Brain Stimulation (DBS) IPG

ABBOTT MEDICAL · Decision date Jul 2, 2026

FDA DECISIONP140009/S132

What did the FDA decide?

FDA records P140009/S132 as a supplement to PMA P140009, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Jul 2, 2026.

FDA approval order statement

for new equipment qualification at a third-tier supplier of the Printed Circuit Board utilized in Abbott's Etema Spinal Cord Stimulation and Liberta Rechargeable Deep Brain Stimulation Implantable Pulse Generators
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Neurology
Decision date
Jul 2, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P140009/S132
Regulatory pathway
PMA supplement
Product code
MHY
Decision code
OK30
Decision date
Jul 2, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stimulator, electrical, implanted, for parkinsonian tremor.

Product code
MHY
FDA device class
3

For the original device and its historical approval scope, see PMA P140009. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P140009 · Original PMA

    BRIO NEUROSTIMULATION SYSTEM

  2. P140009/S118 · Related supplement

    Liberta RC DBS IPG (Model 62400)

  3. P140009/S123 · Related supplement

    Infinity Deep Brain Stimulation (DBS) IPG

  4. P140009/S125 · Related supplement

    DBS Neurostimulation System

  5. P140009/S124 · Related supplement

    Deep Brain Stimulation (DBS) Neurostimulation System

  6. P140009/S127 · Related supplement

    Infinity Deep Brain Stimulation (DBS) System

  7. P140009/S128 · Related supplement

    Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG)

  8. P140009/S126 · Related supplement

    8CH Infinity DBS Lead Kit, 30cm, 0.5, B; 8CH Infinity DBS Lead Kit, 30cm, 1.5, B; 8CH Infinity DBS Lead Kit, 40cm, 0

  9. P140009/S129 · Related supplement

    Infinity Deep Brain Stimulation (DBS) IPG

  10. P140009/S130 · Related supplement

    Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG)

  11. P140009/S131 · Related supplement

    Infinity Deep Brain Stimulation (DBS) IPG; Liberta RC DBS IPG

  12. P140009/S132 received

    Application receipt date recorded by FDA.

  13. P140009/S132 · FDA decision

    30-Day Notice

  14. P140009/S134 · Related supplement

    Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG)

  15. P140009/S138 · Related supplement

    Deep Brain Stimulation (DBS) IPG

  16. P140009/S133 · Related supplement

    Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG)

  17. P140009/S140 · Related supplement

    Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG) Charger

  18. P140009/S143 · Related supplement

    Liberta RC Deep Brain Stimulation (DBS) Implantable Pulse Generator

  19. P140009/S141 · Related supplement

    Deep Brain Stimulation (DBS) EPG

  20. P140009/S142 · Related supplement

    Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG) Charger

  21. P140009/S144 · Related supplement

    Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG)

Timeline entries are records held by MedtechLedger for P140009. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P140009

Product / regulatory recordCompanyPathwayDecision dateSource
ABBOTT MEDICALPMA approvalJun 12, 2015FDA
ABBOTT MEDICALPMA supplementJul 28, 2025FDA
ABBOTT MEDICALPMA supplementAug 29, 2025FDA
Liberta RC DBS IPGP140009/S121
ABBOTT MEDICALPMA supplementSep 7, 2025FDA
ABBOTT MEDICALPMA supplementSep 25, 2025FDA
ABBOTT MEDICALPMA supplementSep 26, 2025FDA
ABBOTT MEDICALPMA supplementNov 7, 2025FDA
ABBOTT MEDICALPMA supplementDec 23, 2025FDA
ABBOTT MEDICALPMA supplementFeb 10, 2026FDA
ABBOTT MEDICALPMA supplementFeb 11, 2026FDA
ABBOTT MEDICALPMA supplementMar 13, 2026FDA
ABBOTT MEDICALPMA supplementApr 25, 2026FDA
ABBOTT MEDICALPMA supplementApr 30, 2026FDA
ABBOTT MEDICALPMA supplementJul 17, 2026FDA
ABBOTT MEDICALPMA supplementJul 26, 2026FDA
ABBOTT MEDICALPMA supplementAug 7, 2026FDA
ABBOTT MEDICALPMA supplementSep 11, 2026FDA
Infinity DBS IPGP140009/S139
ABBOTT MEDICALPMA supplementSep 23, 2026FDA
ABBOTT MEDICALPMA supplementOct 27, 2026FDA
ABBOTT MEDICALPMA supplementOct 28, 2026FDA
ABBOTT MEDICALPMA supplementOct 30, 2026FDA
ABBOTT MEDICALPMA supplementOct 30, 2026FDA

Explore the linked device profile

Other records with product code MHY

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Medical

Headquarters
Not reported
Brand website
abbott.com
FDA applicant address
6901 Prestion Rd., Plano, TX, 75024

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records